These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 29929036)

  • 1. Evaluation of common housekeeping proteins under ischemic conditions and/or rt-PA treatment in bEnd.3 cells.
    Comajoan P; Gubern C; Huguet G; Serena J; Kádár E; Castellanos M
    J Proteomics; 2018 Jul; 184():10-15. PubMed ID: 29929036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of long-term rt-PA effects on bEnd.3 endothelial cells under ischemic conditions; changes in ZO-1 expression and glycosylation of the bradykinin B2 receptor.
    Gubern C; Comajoan P; Huguet G; Sánchez JM; Serena J; Kádár E; Castellanos M
    Thromb Res; 2020 Mar; 187():1-8. PubMed ID: 31935582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cav-1 Protein Levels in Serum and Infarcted Brain Correlate with Hemorrhagic Volume in a Mouse Model of Thromboembolic Stroke, Independently of rt-PA Administration.
    Gubern-Mérida C; Comajoan P; Huguet G; García-Yebenes I; Lizasoain I; Moro MA; Puig-Parnau I; Sánchez JM; Serena J; Kádár E; Castellanos M
    Mol Neurobiol; 2022 Feb; 59(2):1320-1332. PubMed ID: 34984586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant tissue-type plasminogen activator transiently enhances blood-brain barrier permeability during cerebral ischemia through vascular endothelial growth factor-mediated endothelial endocytosis in mice.
    Suzuki Y; Nagai N; Yamakawa K; Muranaka Y; Hokamura K; Umemura K
    J Cereb Blood Flow Metab; 2015 Dec; 35(12):2021-31. PubMed ID: 26219596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant tissue plasminogen activator enhances microparticle release from mouse brain-derived endothelial cells through plasmin.
    Garraud M; Khacef K; Vion AC; Leconte C; Yin M; Renard JM; Marchand-Leroux C; Boulanger CM; Margaill I; Beray-Berthat V
    J Neurol Sci; 2016 Nov; 370():187-195. PubMed ID: 27772757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Escin avoids hemorrhagic transformation in ischemic stroke by protecting BBB through the AMPK/Cav-1/MMP-9 pathway.
    Sun X; Liu Z; Zhou L; Ma R; Zhang X; Wang T; Fu F; Wang Y
    Phytomedicine; 2023 Nov; 120():155071. PubMed ID: 37716034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of rt-PA induced blood-brain barrier component degradation by the poly(ADP-ribose)polymerase inhibitor PJ34 after ischemic stroke in mice.
    Teng F; Beray-Berthat V; Coqueran B; Lesbats C; Kuntz M; Palmier B; Garraud M; Bedfert C; Slane N; Bérézowski V; Szeremeta F; Hachani J; Scherman D; Plotkine M; Doan BT; Marchand-Leroux C; Margaill I
    Exp Neurol; 2013 Oct; 248():416-28. PubMed ID: 23876515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue plasminogen activator disrupts the blood-brain barrier through increasing the inflammatory response mediated by pericytes after cerebral ischemia.
    Yang E; Cai Y; Yao X; Liu J; Wang Q; Jin W; Wu Q; Fan W; Qiu L; Kang C; Wu J
    Aging (Albany NY); 2019 Nov; 11(22):10167-10182. PubMed ID: 31740626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. t-PA, but not desmoteplase, induces plasmin-dependent opening of a blood-brain barrier model under normoxic and ischaemic conditions.
    Freeman R; Niego B; Croucher DR; Pedersen LO; Medcalf RL
    Brain Res; 2014 May; 1565():63-73. PubMed ID: 24675027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined therapy with PJ34, a poly(ADP-ribose)polymerase inhibitor, reduces tissue plasminogen activator-induced hemorrhagic transformations in cerebral ischemia in mice.
    Haddad M; Beray-Berthat V; Coqueran B; Plotkine M; Marchand-Leroux C; Margaill I
    Fundam Clin Pharmacol; 2013 Aug; 27(4):393-401. PubMed ID: 22436003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tacrolimus (FK506) suppresses rt-PA-induced hemorrhagic transformation in a rat thrombotic ischemia stroke model.
    Maeda M; Furuichi Y; Noto T; Matsuoka N; Mutoh S; Yoneda Y
    Brain Res; 2009 Feb; 1254():99-108. PubMed ID: 19101526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the REVERT
    Kirshner ZZ; Gibbs RB
    Mol Cell Endocrinol; 2018 Sep; 473():156-165. PubMed ID: 29396126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of SSAO/VAP-1 in oxygen-glucose deprivation-mediated damage using the endothelial hSSAO/VAP-1-expressing cells as experimental model of cerebral ischemia.
    Sun P; Solé M; Unzeta M
    Cerebrovasc Dis; 2014; 37(3):171-80. PubMed ID: 24503888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of reference genes for gene expression studies in mouse and N2a cell ischemic stroke models using quantitative real-time PCR.
    Kang Y; Wu Z; Cai D; Lu B
    BMC Neurosci; 2018 Feb; 19(1):3. PubMed ID: 29390963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human tissue plasminogen activator protects the basal lamina in experimental focal cerebral ischemia.
    Burggraf D; Martens HK; Jäger G; Hamann GF
    Thromb Haemost; 2003 Jun; 89(6):1072-80. PubMed ID: 12783121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective inhibition of brain endothelial Rho-kinase-2 provides optimal protection of an in vitro blood-brain barrier from tissue-type plasminogen activator and plasmin.
    Niego B; Lee N; Larsson P; De Silva TM; Au AE; McCutcheon F; Medcalf RL
    PLoS One; 2017; 12(5):e0177332. PubMed ID: 28510599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GAPDH and β-actin protein decreases with aging, making Stain-Free technology a superior loading control in Western blotting of human skeletal muscle.
    Vigelsø A; Dybboe R; Hansen CN; Dela F; Helge JW; Guadalupe Grau A
    J Appl Physiol (1985); 2015 Feb; 118(3):386-94. PubMed ID: 25429098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occludin degradation makes brain microvascular endothelial cells more vulnerable to reperfusion injury in vitro.
    Zhang Y; Li X; Qiao S; Yang D; Li Z; Xu J; Li W; Su L; Liu W
    J Neurochem; 2021 Feb; 156(3):352-366. PubMed ID: 32531803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of secretomes from a human blood brain barrier endothelial cells in-vitro model after ischemia by stable isotope labeling with aminoacids in cell culture (SILAC).
    Llombart V; García-Berrocoso T; Bech-Serra JJ; Simats A; Bustamante A; Giralt D; Reverter-Branchat G; Canals F; Hernández-Guillamon M; Montaner J
    J Proteomics; 2016 Feb; 133():100-112. PubMed ID: 26718731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of a mouse cerebral microvascular endothelial cell line (bEnd.3) after oxygen glucose deprivation and reoxygenation.
    Ku JM; Taher M; Chin KY; Grace M; McIntyre P; Miller AA
    Clin Exp Pharmacol Physiol; 2016 Aug; 43(8):777-86. PubMed ID: 27128638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.